STOCK TITAN
  1. Home
  2. APGN

Apexigen Stock Price, News & Analysis

APGN NASDAQ

Company Description

Apexigen (NASDAQ: APGN) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

APGN stock has declined 100.0% over the past year.

This page provides a comprehensive overview of APGN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-100%
Performance 1 year
$0.0
Market Cap
24.9M
Shares outstanding

Apexigen (APGN) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All
-4.63%

Apexigen Announces Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma Presented at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

clinical trial
-33.22%

Apexigen Announces Review of Strategic Alternatives and Restructuring

+8.74%

Apexigen Announces Approximately $2.8 Million Private Placement Financing

private placement
+7.82%

Apexigen Announces New Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, at ASCO Gastrointestinal Cancers Symposium 2023

clinical trial
-6.64%

Apexigen Reports Third Quarter 2022 Financial Results and Provides Business Update

earnings
-1.40%

Apexigen Announces Positive Interim Results from Phase 2 Trial Evaluating its CD40 Antibody, Sotigalimab, in Combination with Doxorubicin in Patients with Liposarcoma

clinical trial

Apexigen has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial, private placement, earnings, conferences. View all APGN news →

SEC Filings

View All

No SEC filings available for APGN.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

APGN Company Profile & Sector Positioning

Apexigen (APGN) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.